# Mycophenolic Acid Monotherapy in Recipients of HLA-identical Living-Related Transplantation

> **NCT01053221** · PHASE2 · TERMINATED · sponsor: **University of Wisconsin, Madison** · enrollment: 16 (actual)

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** Mycophenolic Acid
- **DRUG:** Standard of Care: CNI and MPA

## Key facts

- **NCT ID:** NCT01053221
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-03
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** Funding loss
- **Last updated:** 2019-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01053221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01053221, "Mycophenolic Acid Monotherapy in Recipients of HLA-identical Living-Related Transplantation". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01053221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*